Sonic Healthcare (OTCMKTS:SKHHY) Upgraded at The Goldman Sachs Group

The Goldman Sachs Group upgraded shares of Sonic Healthcare (OTCMKTS:SKHHY) to a strong-buy rating in a research report report published on Friday morning,Zacks.com reports.

Separately, Morgan Stanley set a $28.10 price objective on shares of Sonic Healthcare in a research note on Wednesday, March 19th.

Sonic Healthcare Stock Performance

SKHHY stock opened at $15.62 on Friday. Sonic Healthcare has a 1-year low of $15.24 and a 1-year high of $20.59. The business has a 50-day moving average price of $17.15 and a 200 day moving average price of $17.57.

Sonic Healthcare Cuts Dividend

The company also recently disclosed a dividend, which was paid on Monday, March 31st. Investors of record on Thursday, March 6th were paid a dividend of $0.2816 per share. The ex-dividend date of this dividend was Thursday, March 6th.

About Sonic Healthcare

Sonic Healthcare Limited offers medical diagnostic services to medical practitioners, hospitals, community health services, and their collective patients. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry.